EHYD yields 200000000.00% · PFE yields 6.20%● Live data
📍 EHYD pulled ahead of the other in Year 1
Combined, EHYD + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EHYD + PFE for your $10,000?
ehydrogen Solutions, Inc. engages in the acquisition and development of On Demand Hydrogen Production (ODHP) technologies in the United States. Its technologies are designed to produce hydrogen for integration in to various clean energy distributed power solutions. The company's scope of ODHP technologies enables the integration with fuel cell applications, advanced battery technologies, hydrogen internal combustion engines, and other power generating devices. Its ODHP technologies are available to qualified partners in various vertical and/or geographic markets worldwide, through joint development/adaptation, distribution, and production agreements. The company was formerly known as Big Daddy's BBQ Racing, Inc. and changed its name to ehydrogen Solutions, Inc. in October 2009. ehydrogen Solutions, Inc. was founded in 1987 and is based in Reno, Nevada.
Full EHYD Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.